What is happening. Valganciclovir frequently causes neutropenia and other cytopenias. High-dose or prolonged zinc supplementation can induce copper deficiency, which itself produces neutropenia and anemia. Combining chronic high-dose zinc with a known myelosuppressive antiviral can compound the risk of low neutrophil counts and complicate interpretation of the blood-count abnormalities that already require monitoring during therapy.
Mechanism. Excess zinc upregulates intestinal metallothionein, which binds dietary copper and increases its fecal loss, producing copper deficiency. Copper-deficiency myelopathy causes neutropenia and anemia that are additive to ganciclovir's direct marrow suppression.
Recommendation. Avoid chronic high-dose zinc (generally above roughly 40 mg/day of elemental zinc) while on valganciclovir unless directed by a clinician. Keep any zinc intake within recommended daily amounts, and report new or worsening cytopenias so the cause can be sorted out.